JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 3. Whole-body retention for intraperitoneally (i.p.) or intravenously (i.v.) injected 211At-MX35 ({blacktriangleup}, n = 14 [i.p.] and n = 4 [i.v.]), 211At-88BV59 ({triangleup}, n = 16 [i.p.] and n =4 [i.v.]), 99mTc-MX35 ({blacksquare}, n = 16 [i.p.] and n = 4 [i.v.]), and 99mTc-88BV59 ({square}, n = 10 [i.p.]) at 0, 1, 3, 6, 12, and 18 h after injection. Whole-body retention curves were used to estimate cumulated activity (i.e., AUC) and, hence, the photon contribution to absorbed dose from 99mTc for each individual animal. Values are means ± SEM.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE